In the BioHarmony Drug Report Database

"Preview" Icon

Baclofen

Gablofen, Kemstro, Lioresal, Ozobax (baclofen) is a small molecule pharmaceutical. Baclofen was first approved as Gablofen on 1982-01-01. It is used to treat cerebral palsy, hiccup, huntington disease, intractable pain, and multiple sclerosis amongst others in the USA. It is known to target gamma-aminobutyric acid type B receptor subunit 1. Baclofen’s patent is valid until 2039-08-30 (FDA).

 

Trade Name

 

Gablofen, Kemstro, Lioresal, Ozobax
 

Common Name

 

baclofen
 

ChEMBL ID

 

CHEMBL701
 

Indication

 

cerebral palsy, hiccup, huntington disease, intractable pain, multiple sclerosis, muscle spasticity, neurogenic urinary bladder, spinal cord injuries, spinal cord ischemia, spinal cord neoplasms, spondylolysis, transverse myelitis, trigeminal neuralgia
 

Drug Class

 

Image (chem structure or protein)

Baclofen structure rendering